1. In vitro and in vivo investigation of a novel monoclonal antibody to plasma cells (W5 mAb).
- Author
-
Harper, D., Gollackner, B., Xu, Y., Calderhead, D., Ryan, D., Li, W., Chang, J., Wu, C., Moran, K., Latinne, D., Bazin, H., White-Scharf, M.E., Cooper, D.K.C., and Awwad, M.
- Subjects
MONOCLONAL antibodies ,PLASMA cells ,TRANSPLANTATION of organs, tissues, etc. ,SERUM ,SWINE ,PRIMATES - Abstract
Harper D, Gollackner B, Xu Y, Calderhead D, Ryan D, Li W, Chang J, Wu C, Moran K, Latinne D, Bazin H, White-Scharf ME, Cooper DKC, Awwad M. In vitro and in vivo investigation of a novel monoclonal antibody to plasma cells (W5 mAb). Xenotransplantation 2004; 11: 78–90. © Blackwell Munksgaard, 2004 Natural antibodies (Abs), predominately anti-Gal α1–3Gal (Gal) Abs, in non-human primates and human beings present a major hurdle to successful pig-to-primate xenotransplantation. Attempts to inhibit anti-Gal Ab production in naïve baboons using non-specific immunosuppressive or B cell-specific reagents have failed. A new rat monoclonal antibody (W5 mAb) has been generated, which binds to all B cells, including memory cells, and to the majority of plasma cells, but not to T cells. It has been tested in vitro and in vivo. By immunoprecipitation, W5 mAb bound a human leukocyte antigen class II (HLA-DR) determinant. Sorting splenic or bone marrow W5+ cells resulted in a highly enriched anti-Gal Ab and total immunoglobulin (Ig)-secretory population. In vivo studies in baboons demonstrated that W5 mAb was safe but, despite the concomitant administration of an anti-CD154 mAb to inhibit sensitization, anti-rat Abs were detected within 10 days and inhibited the effect of the W5 mAb. High levels of W5 mAb were able to completely deplete B cells in the blood, but not in lymphoid tissues. Enzyme-linked spot-forming assay (ELISPOT) demonstrated that only 50 to 60% of secreting cells (SC) were depleted in the bone marrow. No reduction in the serum levels of anti-Gal Ab was observed. W5 mAb did not cause complete inhibition of anti-Gal Ab production, probably as a result of its inability to completely deplete B and plasma cells from all lymphoid compartments. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF